Roche Unveils Advanced Test For Enhanced B-Cell Lymphoma Diagnosis

(RTTNews) – Roche (RHHBY) announced the launch of the first clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay, in countries accepting the CE Mark. The test helps differentiate a B-cell cancer fr